STAT3 and cancer: However, what makes curcumin an even more valuable anti-cancer agent is that it can target non-GSCs (GBM cell that do not have GSCs) and effectively target GSCs through different mechanisms such as the induction of mitochondrial ROS, leading to MAPK activation, STAT3 inactivation, and downregulation of STAT3 targets.